Urologists utilize clinical history, elimination diaries, noninvasive urodynamics, and conventional urodynamics to help gain an understanding of each patient’s unique bladder characteristics. It is from this information that urologists can determine whether implementing pharmacologic therapy will benefit a patient; furthermore, this information helps the physician tailor the correct pharmacotherapy to each patient based on their individual bladder physiology. Figure 28.1 shows a treatment algorithm which includes the optimal time to initiate pharmacotherapy for two common urologic issues: frequency and incontinence. There is a multitude of pharmacotherapy agents in an urologist’s armamentarium, and having an in-depth understanding of each agent is key in helping to determine the correct drug needed for each clinical scenario.
- 3.Austin PF, Vricella GJ. Functional disorders of lower urinary tract in children. In: Campbell-walsh urology tenth edition. Part XV Pediatric urology. 2012. pp. 3297–316.Google Scholar
- 9.Gillespie JI, Palea S, Guilloteau V, Guerard M, Lluel P, Korstanje C. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the beta(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction. BJU Int. 2012;110(2 Pt 2):E132–42.CrossRefPubMedGoogle Scholar
- 18.Franco I, Cagliostro S, Collett T, Reda E. The use of alpha blockers to treat urgency/frequency syndrome in children. San Francisco, CA: American Acadamey of Pediatrics Meeting; 2007.Google Scholar